List of insiders holdings for Coherus BioSciences Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| V-Sciences Investments Pte Ltd Temasek Life Sciences Private Ltd Fullerton Management Pte Ltd Temasek Holdings (Private) Ltd 10% Owner | 2020-02-07 09:00:24 | 7,381,116 0 | 7,381,116 | Form 13G |
| KKR Biosimilar L.P. KKR Biosimilar GP LLC KKR Fund Holdings L.P. KKR Fund Holdings GP Ltd KKR Group Holdings L.P. KKR Group Ltd KKR & Co. L.P. KKR Management LLC KRAVIS HENRY R ROBERTS GEORGE R 10% Owner | 2016-04-15 17:04:28 | 3,949,829 0 | 3,949,829 | Form 13D |
| LILLY ELI & CO Lilly Ventures Fund I LLC Former 10% Owner | 2014-11-24 15:31:44 | 3,042,019 0 | 3,042,019 | Form 13G |
| Troendle August J. Director | 2018-02-05 16:07:43 | 49,994 1,910,920 | 1,960,914 | Form 4 |
| Lanfear Dennis M President & CEO | 2024-01-23 20:07:16 | 708,694 519,649 | 1,228,343 | Form 4 |
| FMR LLC See Remark 1 | 2020-01-10 10:24:19 | 950,800 0 | 950,800 | Form 13G |
| Herman Alan C. Chief Scientific Officer | 2017-12-19 16:07:28 | 50,460 300,164 | 350,624 | Form 4 |
| Anicetti Vincent R Chief Operating Officer | 2021-07-08 17:19:29 | 274,790 0 | 274,790 | Form 4 |
| HORTON DARLENE P See Remarks | 2019-01-23 16:05:35 | 225,000 0 | 225,000 | Form 3 |
| FINCK BARBARA K Chief Medical Officer | 2018-09-12 16:05:39 | 119,984 0 | 119,984 | Form 4 |
| Vexler Vladimir Chief Scientific Officer | 2023-04-04 21:02:33 | 116,361 0 | 116,361 | Form 4 |
| Viret Jean-Frederic Chief Financial Officer | 2021-02-03 17:37:27 | 115,462 0 | 115,462 | Form 4 |
| Wahlstrom Mats Director | 2024-02-15 19:56:46 | 0 99,988 | 99,988 | Form 4 |
| Reider Paul Chief Commercial Officer | 2024-01-23 20:05:42 | 81,277 0 | 81,277 | Form 4 |
| Stilwell McDavid Chief Financial Officer | 2024-01-03 16:42:10 | 75,305 0 | 75,305 | Form 4 |
| Watler Peter K. Chief Technical Officer | 2018-02-05 16:07:46 | 55,900 0 | 55,900 | Form 4 |
| Ryan Michael Lee Director | 2023-07-20 17:11:23 | 54,000 0 | 54,000 | Form 4 |
| Erbez Georgia Director | 2024-02-22 17:02:44 | 54,000 0 | 54,000 | Form 4 |
| Newton Charles W. Director | 2023-06-09 16:56:22 | 38,250 0 | 38,250 | Form 4 |
| O'Donnell-Tormey Jill Director | 2023-06-09 16:58:36 | 38,250 0 | 38,250 | Form 4 |
| TZOUMAKAS KIMBERLY JO Director | 2023-06-09 16:59:33 | 38,250 0 | 38,250 | Form 4 |
| Newcomer Lee Nisley Director | 2023-06-09 17:07:15 | 38,250 0 | 38,250 | Form 4 |
| STOLPER MARK Director | 2023-06-09 17:08:14 | 38,250 0 | 38,250 | Form 4 |
| HEALY JAMES Director | 2022-02-11 16:14:30 | 27,000 0 | 27,000 | Form 4/A |
| McMichael Bryan J See Remarks | 2024-01-23 20:04:19 | 22,972 0 | 22,972 | Form 4 |
| MENDELSON ALAN C Director | 2021-05-25 16:51:40 | 20,000 0 | 20,000 | Form 4 |
| Szela Mary T Director | 2021-01-13 16:29:06 | 20,000 0 | 20,000 | Form 4 |
| NUSSBAUM SAMUEL R MD Director | 2021-01-13 16:26:12 | 20,000 0 | 20,000 | Form 4 |
| LAWLIS V BRYAN Director | 2021-01-13 16:25:17 | 20,000 0 | 20,000 | Form 4 |
| Satvat Ali J. Director | 2020-01-14 17:55:26 | 20,000 0 | 20,000 | Form 4 |
| Richards Christos Director | 2020-01-14 17:52:03 | 20,000 0 | 20,000 | Form 4 |
| Daiichi Sankyo Company LTD Former 10% Owner | 2019-02-13 16:17:02 | 0 0 | 0 | Form 13G |